A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells

Integrative Cancer Therapies

Volumn 13, Issue 2, 2014, Pages 152-160

  Xiong, Fei ^a,b   Jiang, Miao ^a   Huang, Zhenzhou ^a   Chen, Meijuan ^a   Chen, Kejun ^c   Zhou, Jing ^a   Yin, Lian ^a   Tang, Yuping ^a   Wang, Mingyan ^a   Ye, Lihong ^a   Zhan, Zhen ^a   Duan, Jinao ^a   Fu, Haian ^c   Zhang, Xu ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b SOOCHOW UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; cell cycle; cisplatin; non small cell lung cancer; PI3K AKT pathway; Zhou's formula of Ke Jin Yan

Indexed keywords

APOPTOSIS; CELL CYCLE; CISPLATIN; NON-SMALL CELL LUNG CANCER; PI3K/AKT PATHWAY; ZHOU'S FORMULA OF KE JIN YAN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HERBAL MEDICINE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; PHOSPHATIDYLINOSITOL 3-KINASES; PLANT PREPARATIONS; PROTO-ONCOGENE PROTEINS C-AKT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84894429312     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735413503544     Document Type: Article

References (43)

1. Tamiya M, Kobayashi M, Morimura O, et al. Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer. Clin Lung Cancer. 2013 ; 14: 50-54
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002 ; 52: 23-47
3. Xu T, Wei Q, Guerra JL, et al. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 ; 84: e229 - e235
4. De Ruysscher D, Van Meerbeeck J, Vandecasteele K, et al. Radiation-induced oesophagitis in lung cancer patients: is susceptibility for neutropenia a risk factor?. Strahlenther Onkol. 2012 ; 188: 564-567
5. Castel M, Pathak A, Despas F, Mazières J. Adverse effects of new biological therapies for non-small-cell bronchial cancer. Presse Med. 2011 ; 40 (4 pt 1). 415-419
6. Ji XM, Ouyang B, Liu H, et al. In vitro and in vivo inhibitory effect of the combination of Wenxia Changfu formula with cisplatin in non-small cell lung cancer. Chin J Integr Med. 2011 ; 17: 908-916
7. Liu J, Hu XJ, Jin B, Qu XJ, Hou KZ, Liu YP. β-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells. J Pharm Pharmacol. 2011 ; 64: 146-153
8. Yin H, Guo R, Xu Y, et al. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer. Acta Biochim Biophys Sin (Shanghai). 2012 ; 44: 147-153
9. Zhang L, Ruan J, Yan L, et al. Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells. Molecules. 2012 ; 17: 3736-3750
10. Ji H The clinical observation of treatment of later Period non-small cell lung cancer by treated with modified Zhoushi Kejinyan combined with TP cheotherapy. Nanjing, China: Nanjing University of Traditional Chinese Medicine ; 2011:
11. Lan C, Li L, Zhou Z. Medical master Professor Zhou Zhongying's four experiences in treating cancer. J Tradit Chin Med. 2011 ; 5: 11-13
12. Lin S, Wang Z, Zhou Z. Professor Zhou Zhongying's experience on "complex act of generosity" in treating 1 case of lung cancer. J Henan Tradit Chin Med. 2010 ; 7: 717-718
13. Wang P, She G, Yang Y, et al. Synthesis and biological evaluation of new ligustrazine derivatives as anti-tumor agents. Molecules. 2012 ; 17: 4972-4985
14. Zhang P, Wang X, Xiong S, et al. Genome wide expression analysis of the effect of the Chinese patent medicine Zilongjin tablet on four human lung carcinoma cell lines. Phytother Res. 2011 ; 25: 1472-1479
15. Polier G, Ding J, Konkimalla BV, et al. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis. 2011 ; 2: e182
16. Cheng HM, Li CC, Chen CY, et al. Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation. J Ethnopharmacol. 2010 ; 132: 429-437
17. Sigstedt SC, Hooten CJ, Callewaert MC, et al. Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. Int J Oncol. 2008 ; 32: 1085-1090
18. Warner BJ, Blain SW, Seoane J, Massague J. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Mol Cell Biol. 1999 ; 19: 5913-5922
19. Scrima M, De Marco C, Fabiani F, et al. Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase. PLoS One. 2012 ; 7: e30427
20. Zito CR, Jilaveanu LB, Anagnostou V, et al. Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells. PLoS One. 2012 ; 7: e31331
21. Chou PY, Huang GJ, Pan CH, et al. Trilinolein inhibits proliferation of human non-small cell lung carcinoma A549 through the modulation of PI3K/Akt pathway. Am J Chin Med. 2011 ; 39: 803-815
22. Acharya BR, Bhattacharyya S, Choudhury D, Chakrabarti G. The microtubule depolymerizing agent naphthazarin induces both apoptosis and autophagy in A549 lung cancer cells. Apoptosis. 2011 ; 16: 924-939
23. Espinosa I, Catasus L, Canet B, D'Angelo E, Munoz J, Prat J. Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis. Mod Pathol. 2011 ; 24: 846-854
24. Tang JM, He QY, Guo RX, Chang XJ. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis. Lung Cancer. 2006 ; 51: 181-191
25. Akca H, Demiray A, Aslan M, Acikbas I, Tokgun O. Tumour suppressor PTEN enhanced enzyme activity of GPx, SOD and catalase by suppression of PI3K/AKT pathway in non-small cell lung cancer cell lines. J Enzyme Inhib Med Chem. 2013 ; 28: 539-544
26. Lee JW, Min HY, Han AR, et al. Growth inhibition and induction of G1 phase cell cycle arrest in human lung cancer cells by a phenylbutenoid dimer isolated from Zingiber cassumunar. Biol Pharm Bull. 2007 ; 30: 1561-1564
27. Arora S, Bhardwaj A, Srivastava SK, et al. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS One. 2011 ; 6: e21573
28. Fedorov SN, Shubina LK, Bode AM, Stonik VA, Dong Z. Dactylone inhibits epidermal growth factor-induced transformation and phenotype expression of human cancer cells and induces G1-S arrest and apoptosis. Cancer Res. 2007 ; 67: 5914-5920
29. Mateen S, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Mol Carcinog. 2010 ; 49: 247-258
30. Baldi A, De Luca A, Esposito V, Campioni M, Spugnini EP, Citro G. Tumor suppressors and cell-cycle proteins in lung cancer. Pathol Res Int. 2011 ; 2011: 605042
31. Vincenzi B, Schiavon G, Silletta M, et al. Cell cycle alterations and lung cancer. Histol Histopathol. 2006 ; 21: 423-435
32. Vonlanthen S, Heighway J, Kappeler A, Altermatt HJ, Borner MM, Betticher DC. p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer. Int J Oncol. 2000 ; 16: 951-957
33. Zhao YF, Wang CR, Wu YM, Ma SL, Ji Y, Lu YJ. P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment. Biomed Pharmacother. 2011 ; 65: 151-156
34. Zhao Y, Wu S, Wu J, et al. Introduction of hypoxia-targeting p53 fusion protein for the selective therapy of non-small cell lung cancer. Cancer Biol Ther. 2011 ; 11: 95-107
35. Lu Y, Muller M, Smith D, et al. Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling. Oncogene. 2011 ; 30: 4567-4577
36. Sabile AA, Arlt MJ, Muff R, et al. Cyr61 expression in Osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice. J Bone Miner Res. 2012 ; 27: 58-67
37. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta. 1992 ; 1114: 147-162
38. Ong CS, Zhou J, Ong CN, Shen HM. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-cyclin D1 pathway. Cancer Lett. 2010 ; 298: 167-175
39. Chen B, Pan H, Zhu L, Deng Y, Pollard JW. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase→AKT→GSK-3β→cyclin D1→pRB pathway to block uterine epithelial cell proliferation. Mol Endocrinol. 2005 ; 19: 1978-1990
40. Hashimoto T, He Z, Ma WY, et al. Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res. 2004 ; 64: 3344-3349
41. Wu CS, Chen YJ, Chen JJ, et al. Terpinen-4-ol induces apoptosis in human nonsmall cell lung cancer in vitro and in vivo. Evid Based Complement Alternat Med. 2012 ; 2012: 818261
42. Wong BS, Hsiao YC, Lin TW, et al. The in vitro and in vivo apoptotic effects of Mahonia oiwakensis on human lung cancer cells. Chem Biol Interact. 2009 ; 180: 165-174
43. Jackson T, Chougule MB, Ichite N, Patlolla RR, Singh M. Antitumor activity of noscapine in human non-small cell lung cancer xenograft model. Cancer Chemother Pharmacol. 2008 ; 63: 117-126